|
Authored by:
- AdventHealth Research Institute
|
Estimated read time:
Approximately 1 billion people throughout the world suffer from tinnitus (ringing in the ears), and it is the number one disability of those who serve in the U.S. military. The condition can disrupt sleep and concentration, negatively impacting daily quality of life and mental health. There is currently no cure.
That is why the AdventHealth Research Institute is excited to be participating in a new multi-site clinical trial funded by the U.S. Department of Defense. Under the leadership of Principal Investigator Michael Seidman, MD, this study will evaluate the efficacy of etanercept, a TNF-alpha blocker, as a potential treatment for blast-induced tinnitus. Click the button below to learn more.
Recent News
-
News
Under the leadership of Principal Investigator Valeria Baldivieso, MD, and Sub-Investigator Chandan Reddy, MD, MS, FAANS, the AdventHealth Research Institute is recruiting patients for the Exablate...
-
News
New Study Published in the New England Journal of Medicine Shows the Addition of Regional Nodal Irradiation Does Not Decrease Rate of Invasive Breast Cancer Recurrence in Patients with Negative...
-
News
For people with Type 1 diabetes (T1D), low blood sugar episodes—also known as hypoglycemia—can strike fast and hard. The body’s natural defense is to release hormones like glucagon to raise blood...